Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
1.
Curr Med Chem ; 17(33): 4018-26, 2010.
Artigo em Inglês | MEDLINE | ID: mdl-20939824

RESUMO

Cardiovascular disease is the largest cause of death in Western societies and it primarily results from atherosclerosis of large and medium-sized vessels. Atherosclerosis leads to myocardial infarction, when it occurs in the coronary arteries, or stroke, when it occurs in the cerebral arteries. Pathological processes involved in macrovascular disease include the accumulation of lipids which are retained by extracellular matrix (ECM) molecules, especially by the chondroitin sulfate/dermatan sulfate (CS/DS) proteoglycans (CS/DSPGs), such as versican, biglycan and decorin. The sulfation pattern of CS is a key player in protein interactions causing atherosclerosis. Several studies have shown that lipoproteins bind CSPGs via their glycosaminoglycan chains. Galactosaminoglycans, such as CS and DS, bind low density lipoproteins (LDL), affecting the role of these molecules in the arterial wall. In this article, the role of CS and versican in atherosclerosis and hyaluronan in atherogenesis as well as the up to date known mechanisms that provoke this pathological condition are presented and discussed.


Assuntos
Aterosclerose/metabolismo , Glicosaminoglicanos/metabolismo , Ácido Hialurônico/metabolismo , Proteoglicanas/metabolismo , Versicanas/metabolismo , Animais , Aterosclerose/tratamento farmacológico , Aterosclerose/fisiopatologia , Sulfatos de Condroitina/metabolismo , Dermatan Sulfato/análogos & derivados , Dermatan Sulfato/metabolismo , Matriz Extracelular/metabolismo , Proteínas da Matriz Extracelular/metabolismo , Humanos , Lipoproteínas LDL/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA